GF
CERE

Gabelli Funds’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Gabelli Funds’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-347,624
Closed -$14.2M – 1147
2024
Q2 		$14.2M Sell
347,624
-296,235
-46% -$12.3M 0.11% 251
2024
Q1 		$27.2M Buy
643,859
+178,238
+38% +$7.49M 0.2% 139
2023
Q4 		$19.7M Buy
+465,621
New +$13.4M 0.15% 182

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Gabelli Funds's CERE Position: Q3 2024 in Review

Gabelli Funds sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 347,624 shares — an estimated $14.2M sold.

Gabelli Funds first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $27.2M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Gabelli Funds reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Gabelli Funds sold 347,624 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $14.2M.
  • Gabelli Funds first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Gabelli Funds's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $27.2M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Gabelli Funds's 13F filing for Q3 2024, filed 13 Nov 2024.